2024
|
Invention
|
Compactable oral formulations of ibutamoren.
The present disclosure relates to pharmaceutical so... |
2023
|
Invention
|
Compositions for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepa... |
2022
|
Invention
|
Compactable oral formulations of ibutamoren. The present disclosure relates to pharmaceutical sol... |
|
Invention
|
Detecting and treating growth hormone deficiency.
Described herein is a new oral method for usin... |
2021
|
G/S
|
Therapeutic pharmaceuticals to treat rare diseases in children, namely Pediatric Growth Hormone D... |
2020
|
Invention
|
Detecting and treating growth hormone deficiency. Described herein is a new oral method for using... |
|
Invention
|
Salts and prodrugs of 1-methyl-d-tryptophan. Presently provided are indoximod prodrug and salt co... |
2019
|
Invention
|
Salts and prodrugs of 1-methyl-d-tryptophan.
Presently provided are indoximod prodrug and salt c... |
|
Invention
|
Compositions for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepat... |
2018
|
Invention
|
Synthesis of cyclocreatine and analogs thereof. Provided herein is a process and intermediates fo... |
2016
|
Invention
|
Cyclocreatine microsuspension.
Provided is a microsuspension comprising cyclocreatine, or an ana... |
|
Invention
|
Cyclocreatine microsuspension. Provided is a microsuspension comprising cyclocreatine, or an anal... |
2015
|
Invention
|
Synthesis of cyclocreatine and analogs thereof. Provided herein is a process for the preparation ... |
|
G/S
|
providing medical information in the field of orphan drugs developed to treat rare diseases |
2014
|
Invention
|
Carbohydrate-modified glycoproteins and uses thereof.
The present invention provides immunogenic... |
2012
|
Invention
|
Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes. The invent... |
2011
|
Invention
|
Enhanced immunogenicity of tumor associated antigens by addition of αgal epitopes. The invention ... |
2007
|
Invention
|
Methods for treating sarcopenia with a growth hormone secretagogue. The present invention relates... |